Get the Latest Funding and Biotech News

Lonza renews partnership with BaseLaunch

Building on a strong collaboration, Lonza and BaseLaunch have renewed their partnership to further support the development of innovative therapeutics. As a Domain Partner, Lonza…

Anaveon Appoints Thaminda Ramanayake as CEO

Basel, Switzerland, March 23, 2026 – Anaveon, a late-stage preclinical biotech focused on reprogramming the immune system with precision biologics, announces today the appointment of…

Vossius renews partnership with BaseLaunch

We are delighted to announce that Vossius is continuing its partnership with BaseLaunch to support cutting-edge early-stage biotechs in protecting and strengthening their innovations, helping…

Umlaut.bio joins BaseLaunch portfolio

We’re excited to welcome Umlaut.bio to our portfolio. Umlaut.bio, a spin-off from EMBL in Heidelberg, is pioneering the development of small molecules inhibiting tRNA modifications…

FimmCyte Announces Collaboration with Gedeon Richter

Basel, February 18th, 2026 - FimmCyte AG (“FimmCyte”), a pioneering Swiss biotech developing targeted immunotherapies for chronic fibro-inflammatory diseases, announces a strategic research collaboration and…

Pfizer becomes a BaseLaunch partner

Basel, Switzerland - February 10, 2026 — BaseLaunch, a platform partnering with scientists and entrepreneurs to launch, fund, and build early biotech ventures, announced today the…

We welcome Catalent as our new domain partner

We are pleased to announce a partnership with Catalent, Inc., a global contract development and manufacturing organization (CDMO) supporting pharmaceutical, biotech and consumer health companies…

Takeda becomes a BaseLaunch partner

Basel, Switzerland - December 16, 2025 — BaseLaunch, a platform to launch, fund, and build early biotech ventures developing cutting-edge therapeutics, announced today Takeda has…

Aukera Therapeutics Comes Out of Stealth

Basel, Switzerland - 11 December 2025, Aukera Therapeutics, a preclinical-stage biotech spin-off from the University of Basel is officially coming out of stealth as it enters…

Gibela Publishes New Findings on CNNM4 in Metabolic Disease

Basel, Switzerland - 14 November 2025, Gibela Therapeutics GmbH (“Gibela”), the Basel-based Biotech focusing on the treatment of liver diseases using siRNA technology to target…

Tolremo Announces Positive TT125-802 Results at ESMO 2025

Basel, Switzerland - October 17, 2025, TOLREMO therapeutics AG (TOLREMO) today announced encouraging clinical data from 34 patients with advanced solid tumors treated with TT125-802…

Alentis appoints Dr. Mark Pruzanski as CEO

Basel, Switzerland – Oct 15, 2025, Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing first-in-class therapies targeting claudin-1 for a range of fibrosis and oncology…

Synendos Reports Positive Phase 1 Results for SYT-510, Preparing for Phase 2

Basel, Switzerland - September 24, 2025, Synendos Therapeutics (“Synendos”), the clinical-stage biotech company developing breakthrough therapies for neuropsychiatric disorders, announced today topline results for its…

metaLead Therapeutics Appoints David Urech as Member of the Board of Directors

Basel, Switzerland – September 23, 2025 – metaLead Therapeutics AG (“metaLead”) announces the appointment of David Urech, PhD, Founder and former Chief Executive Officer of…

Gibela publishes groundbreaking research in Hepatology

We are pleased to share that the research of Gibela Therapeutics, our portfolio company, was featured on the cover of the Hepatology journal. The company is…

Synendos Appoints Dr. George Garibaldi as Chief Medical Officer

Basel, Switzerland – Synendos Therapeutics, the clinical-stage biotechnology company developing breakthrough therapies for neuropsychiatric disorders, announced the appointment of Dr. George Garibaldi as Chief Medical…

We welcome BioDuro as our new domain partner

We’re excited to share our new partnership with BioDuro, a trusted CRDMO with a 29-year proven track record and strong reputation for delivering high-quality, end-to-end…

BaseLaunch Summer Get-Together 2025

Our summer get-together brought people from across the biotech ecosystem, from founders and scientists, to investors, partners, and beyond, for an evening that combined meaningful…

News